Endura Therapeutics
acquired
acquired
Stage
About
Endura Therapeutics develops CRISPR-based oral medicines as accessible alternatives to traditional genetic medicines.
Explore Endura Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.